Low-Dose Ketamine Infusion During Burn Wound Care
Recruiting now · Phase 4 · Has a placebo group
Conditions studied: Burn, Pain, Dissociation, Opioid
In brief
The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.
Key facts
- Study ID
- NCT06506565
- Run by
- University of Tennessee
- People needed
- 140
- Starts
- 2024-07-08
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2024-12-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Admitted to burn service with thermal injury
You may not qualify if…
- unable/unwilling to consent within 72 hours
- unable to report NRS
- known contraindication to ketamine
- < than 18 years of age
- pregnant
- incarcerated
- TBSA over 50 %
Where it is running
- Regional One Health — Memphis, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.